Re-Code

Your Health and Life

we are dedicated to fostering a healthy life, promoting graceful aging, and preventing illness. 


Our mission is to revolutionize healthcare by re-coding the way we approach disease and healing.

ABOUT

Re-Code

Your Health and Life

We develop individualized treatment plans based on the analysis of extracellular

vesicles (EVs) in the patient's blood, optimizing therapeutic outcomes.


Neural Tube-Derived Stem Cells (NT-SCs) for Brain Disorders

Neural tube-derived stem cell platform using tissue from ectopic pregnancies at 6–8 weeks of gestation. NT-SCs demonstrate robust and stable differentiation into neurons, astrocytes, and oligodendrocytes—making them highly suitable for treating central nervous system disorders.


Fetal-Derived MSCs & EVs for Anti-Aging and Inflammatory Diseases 

These early-stage MSCs exhibit exceptional regenerative properties, enhanced immunomodulatory capacity, and superior exosome production efficiency.


EV-Based Diagnostic and Therapeutic Technologies

By combining placenta-derived EVs with recombinant growth factors, RE-CODE is advancing a new class of regenerative therapeutics that function without the need for whole-cell transplantation. This platform serves as a cornerstone for future non-cell-based therapies.

TECHNOLOGY

Stem Cell

Technology 

Our mission is to restore cell health and resilience through cell rejuvenation, aiming to reverse diseases, injuries, and disabilities

that can occur throughout life. By utilizing innovative technologies such as extracellular vesicles for diagnosis and treatment, 


and stem cells for therapeutic interventions, we strive to advance early diagnosis and treatment of various diseases.

PRODUCT

Extracellular

Vesicles

We develop individualized treatment plans based on the analysis of extracellular vesicles (EVs) in the patient's blood,

optimizing therapeutic outcomes.

ABOUT

Re-Code

Your Health and Life 

We develop individualized treatment plans based on the analysis of BioNanocarrier in the patient's blood, optimizing therapeutic outcomes.


Pure neurogenic origined Stem Cells for Brain Disorders

Brain Tissue-derived Stem cells(BTS) platform using pure neurogenic origin. BTS demonstrate robust and stable differentiation into neurons, astrocytes, and oligodendrocytes—making them highly suitable for treating central nervous system disorders.


Pure neurogenic origined MSCs & BioNanocarrie for Anti-Aging and Inflammatory Diseases

These early-stage MSCs exhibit exceptional regenerative properties, enhanced immunomodulatory capacity, and superior BioNanocarrier production efficiency.


BioNanocarrie-Based Diagnostic and Therapeutic Technologies

By combining pure neurogenic origined BioNanocarrier with recombinant growth factors, RE-CODE is advancing a new class of regenerative therapeutics that function without the need for whole-cell transplantation. This platform serves as a cornerstone for future non-cell-based therapies.

TECHNOLOGY

Stem Cell

Technology 

Our mission is to restore cell health and resilience through

cell rejuvenation, aiming to reverse diseases, injuries, and disabilities

that can occur throughout life. By utilizing innovative technologies

such as BioNanocarrier for diagnosis and treatment, 


and stem cells for therapeutic interventions, we strive to advance

early diagnosis and treatment of various diseases.

PRODUCT

BioNanocarrie

We develop individualized treatment plans based on the

analysis of BioNanocarrier in the patient's blood,

optimizing therapeutic outcomes.


CHA University Startup Incubation Center,
Room 305-243, Beolmal-ro 30 bun-gil, Bundang-gu, Seongnam-si, Gyeonggi-do

CHA University Startup Incubation Center, 
Room 305-243, Beolmal-ro 30 bun-gil, Bundang-gu, Seongnam-si, Gyeonggi-do